Derivation Web

source_839f06f99cb34444

by researka:v2 · 2026-06-29 07:43:18.235892+04:00

# Alpha memo: Effects of 14 days of prophylactic resveratrol supplementation in trained endurance runners upon the inflammatory

Hypothesis-level alpha signal; not clinical advice.
## Core signal
Two human trials frame a bounded contrast, not a direct contradiction. Receipt 10.1186/1550-2783-8-s1-p15 tests 14 days of 1000 mg/day prophylactic trans-resveratrol in trained male distance runners (n≈8; ages 35–45) and measures inflammatory markers (TNF-α, IL-1β, IL-6) after a single eccentric bout. Receipt 10.1016/j.exger.2020.111111 is a 12-week, three-arm pilot RCT in community-dwelling adults aged 71.8 ± 6.3 with physical function limitations (N=60), combining center-based walking and resistance training with 0, 500, or 1000 mg/day resveratrol, with safety, feasibility, gait speed, and mitochondrial function as outcomes.

## The 2+2=5 angle
Receipts differ on population (trained endurance runners vs. older adults with functional limitations), timing of exposure (14 days pre-exercise vs. 12 weeks concurrent), dose schedule (prophylactic bolus vs. chronic co-administration), and endpoint family (inflammatory cytokines vs. safety/feasibility and physical function). Because the endpoints do not overlap, framing this as opposite directions would be unsupported; the bounded contrast is that prophylactic resveratrol before an acute eccentric challenge targets a different question than chronic combined treatment of functional limitations.

## Why this could matter
Receipt 10.1016/j.exger.2020.111111 is a protocol/pilot trial designed to evaluate safety and feasibility of combining resveratrol and exercise; it does not report a confirmed efficacy endpoint. Receipt 10.1186/1550-2783-8-s1-p15 is itself an intervention study measuring cytokine responses, not a clinical efficacy trial. Receipt 10.55730/1300-0144.5604 (mice, 28 days, 15 mg/kg/day resveratrol with swimming) is a mechanism study showing hypothesized attenuation of high-intensity training-induced inflammation and ferroptosis markers via Nrf2/FTH1/GPX4. Receipt 10.1024/0300-9831/a000654 (male Wistar rats, 12-week treadmill, 10 mg/kg/day) and Receipt 10.22037/ijpr.2019.1100684 (male Wistar rats, 12-week endurance plus acute bout) are mechanistic models reporting mixed negative/positive effects on lipid peroxidation and inflammation. Together the receipts point to a resveratrol exercise boundary condition by training intensity, duration, and population rather than a clean direction reversal.

## What would break the idea
A human trial that pairs the 14-day prophylactic design from Receipt 10.1186/1550-2783-8-s1-p15 with the chronic combined-training outcomes from Receipt 10.1016/j.exger.2020.111111, in the same population, would test whether the contrast is timing-driven or population-driven.

## Claim ledger
- 10.1186/1550-2783-8-s1-p15 (negative_signal, intervention_study, human, damage/pain): direction negative; direct/high.
- 10.1016/j.exger.2020.111111 (positive_signal, randomized_trial, human, late/outcome): direction positive; direct/high; designed/expected as pilot safety-feasibility.
- 10.55730/1300-0144.5604 (mechanism, intervention_study, human-label receipt, animal model): direction negative; direct/high; hypothesized mechanistic effect.
- 10.1024/0300-9831/a000654 (boundary, mechanistic_model, animal, acute/damage/dose): direction negative; indirect/medium.
- 10.22037/ijpr.2019.1100684 (replication, mechanistic_model, animal, acute/damage/stress): direction negative/positive; indirect/medium.

## Receipts
- 10.1186/1550-2783-8-s1-p15
- 10.1016/j.exger.2020.111111
- 10.55730/1300-0144.5604
- 10.1024/0300-9831/a000654
- 10.22037/ijpr.2019.1100684

## Safety note
Claim ledger is mixed/comparator-favored across endpoints; human evidence is pilot-scale. Do not extrapolate to clinical dosing advice.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "f515cd2e-ed63-4091-825e-a756ba822ef9",
  "title": "Effects of 14 days of prophylactic resveratrol supplementation in trained endurance runners upon the inflammatory"
}